Pilot study of tocilizumab monotherapy for active chronic periaortitis
Objectives To investigate the effectiveness and safety of TCZ (tocilizumab) monotherapy for chronic periaortitis (CP) patients at acute active stage.Methods Twelve patients with definite or possible diagnosis of CP were enrolled and received intravenous infusions of TCZ (8 mg/kg) every 4 weeks for a...
Main Authors: | Wen Zhang, Zheng Liu, Yunyun Fei, Jieqiong Li, Yu Peng, Hui Lu, Linyi Peng, Jiaxin Zhou, Anqi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-03-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/1/e003007.full |
Similar Items
-
IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
by: Linyi Peng, et al.
Published: (2020-05-01) -
The Differential Diagnosis of Two Cases of Chronic Periaortitis
by: Takao Kato, et al.
Published: (2013-01-01) -
TLR-4 and VEGF polymorphisms in chronic periaortitis.
by: Fabiola Atzeni, et al.
Published: (2013-01-01) -
Isolated periaortitis: Clinical and imaging characteristics
by: Abdel-Rauf Zeina, et al.
Published: (2008-01-01) -
Chronic Periaortitis (Retroperitoneal Fibrosis) Concurrent with Recurrent Cutaneous Eosinophilic Vasculitis
by: Despoina Kiorpelidou, et al.
Published: (2011-01-01)